NERV - Minerva Neurosciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
288.01M
Enterprise Value 3
232.3M
Trailing P/E
N/A
Forward P/E 1
-4.65
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
5.26
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-4.07

Trading Information

Stock Price History

Beta (3Y Monthly) 1.62
52-Week Change 3-5.63%
S&P500 52-Week Change 318.18%
52 Week High 38.83
52 Week Low 34.01
50-Day Moving Average 35.47
200-Day Moving Average 36.01

Share Statistics

Avg Vol (3 month) 3383.86k
Avg Vol (10 day) 3346.04k
Shares Outstanding 539.03M
Float 33.6M
% Held by Insiders 13.79%
% Held by Institutions 181.12%
Shares Short (Nov 29, 2019) 43.63M
Short Ratio (Nov 29, 2019) 49.81
Short % of Float (Nov 29, 2019) 414.75%
Short % of Shares Outstanding (Nov 29, 2019) 49.30%
Shares Short (prior month Oct 31, 2019) 42.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.32%
Return on Equity (ttm)-70.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -57.11M
Net Income Avi to Common (ttm)-55.47M
Diluted EPS (ttm)-1.42
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)59.93M
Total Cash Per Share (mrq)1.54
Total Debt (mrq)324.14k
Total Debt/Equity (mrq)0.58
Current Ratio (mrq)6.20
Book Value Per Share (mrq)1.42

Cash Flow Statement

Operating Cash Flow (ttm)-39.05M
Levered Free Cash Flow (ttm)-18.49M